Anticytokine approaches in pulmonary fibrosis: Bringing factors into focus

Thorax

Volumn 52, Issue 3, 1997, Pages 294-296

  Coker, R K ^a   Laurent, G J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

anticytokine; pulmonary fibrosis

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; DECORIN; GROWTH FACTOR; INTERLEUKIN 1; LYMPHOTOXIN; MANNOSE 6 PHOSPHATE;

ARTICLE; HUMAN; LUNG FIBROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030963536     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.3.294     Document Type: Article

References (12)

1. Coker RK, Laurent GJ. Pathogenesis of pulmonary fibrosis: implications for pharmacological intervention. In: Walter EH, du Bois RM, eds. Immunology and management of interstitial lung disease. London: Chapman and Hall, 1995: 19-36.
2. Cambrey A, Harrison NK, Dawes KE, Southcott AM, Black CM, du Bois RM, et al. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol 1994;11:439-45.
3. Hernandez-Rodriguez NA, Cambrey AD, Harrison NK, Chambers RC, Gray AJ, Southcott AM, et al. Role of thrombin in pulmonary fibrosis. Lancet 1995;346:1071-3.
4. 3 all stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 1997 (in press).
5. Piguet PF, Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J 1994;7:515-8.
6. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, et al. Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis. J Clin Invest 1995;96:250-9.
7. Prior C, Haslam P. In vivo levels and in vitro production of interferon gamma in fibrosing interstitial lung diseases. Clin Exp Immunol 1992;88:280-7.
8. 1 inhibits proteoglycan synthesis in arterial wall. J Vasc Res 1994;31:322-9.
9. Fakhrai H, Dorigo D, Shawler DL, Lin H, Mercola D, Black KL, et al. Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc Natl Acad Sci USA 1996;93:2909-14.
10. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
11. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, et al. Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992;360:361-4.
12. Isaka Y, Breese DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med 1996;2:418-23.